BULLHEAD CITY — Valley View Medical Center (VVMC) is transforming neurological care for critically ill patients with the adoption of the Ceribell System, an FDA-cleared electroencephalography (EEG) device powered by artificial intelligence (AI). Designed for rapid seizure detection and continuous monitoring, this groundbreaking technology enables hospital teams to quickly make critical treatment decisions and potentially provide better outcomes for patients at risk of non-convulsive seizures.
Non-convulsive seizures present a significant challenge in acute care. These seizures occur without obvious symptoms, making them difficult to detect and often delaying treatment. Like convulsive seizures, without prompt management with anti-seizure medication, non-convulsive seizures can become more difficult to manage, progress to status epilepticus and potentially lead to increased rates of cognitive morbidity and mortality. Millions of ICU and emergency department patients across the U.S. are at risk for these silent seizures, commonly triggered by conditions such as brain injuries, cardiac arrest, stroke, or sepsis. Similar to stroke, “time is brain” for seizures—prompt diagnosis and intervention are critical as treatment efficacy declines with every hour of delay.
The Ceribell System includes an easy to apply headband, a portable recorder, and intuitive AI-driven software. Setup takes less than 10 minutes, giving clinicians immediate access to EEG data for timely, informed decision-making. A recent retrospective analysis found that compared to conventional EEG, initial assessment with Ceribell was associated with a median reduction of ICU stay by 4 days.
“We are excited to partner with Ceribell to bring this cutting-edge brain diagnostic technology to our patients,” said Blake Hubbard, CEO at Valley View Medical Center. “Similar to strokes, with seizures, every minute counts, so early detection is vital in providing the best possible treatment. By incorporating the Ceribell EEG system into our diagnostic toolkit, we can save critical time and change how we assess and treat our critically ill neurology patients.”
This technology is not meant to replace conventional EEG monitoring; it is a complementary solution that enables expanded EEG coverage throughout the hospital. With Ceribell, clinicians can rapidly and more accurately diagnose and manage seizures in the acute care setting, which may reduce the need to transfer patients to other facilities and help us to improve patient outcomes.
